IDEAS home Printed from https://ideas.repec.org/h/pal/palchp/978-0-230-36353-3_8.html
   My bibliography  Save this book chapter

Dr Reddy’s Global Strides — Will the Success Story Continue?

In: India: Acquiring its Way to a Global Footprint

Author

Listed:
  • Lekha Ravi

Abstract

In February 2006, Dr Reddy’s Laboratories Limited (DRL) acquired the fourth largest generic pharmaceutical company in Germany, Betapharm Arzneimittel GmbH (Betapharm) from the 3i Group PLC (3i) paying US $570 million (€480 million). This acquisition was funded through a combination of internal accruals and borrowings. Immediately after the deal, health care reforms took place in Germany setting lower reference prices for drugs, forcing companies to cut prices. Many analysts felt that DRL had paid too much for the acquisition as the valuation of the deal was approximated to be more than thrice the annual sales of Betapharm. Would DRL be able to prove the critics wrong and realise their ambition of becoming a US $1 billion mid-size global pharmaceutical company by 2008?

Suggested Citation

  • Lekha Ravi, 2012. "Dr Reddy’s Global Strides — Will the Success Story Continue?," Palgrave Macmillan Books, in: Suseela Yesudian (ed.), India: Acquiring its Way to a Global Footprint, chapter 8, pages 91-102, Palgrave Macmillan.
    • Handle: RePEc:pal:palchp:978-0-230-36353-3_8
    DOI: 10.1057/9780230363533_8
    as

    Download full text from publisher

    To our knowledge, this item is not available for download. To find whether it is available, there are three options:
    1. Check below whether another version of this item is available online.
    2. Check on the provider's web page whether it is in fact available.
    3. Perform a search for a similarly titled item that would be available.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:pal:palchp:978-0-230-36353-3_8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.palgrave.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.